Have a personal or library account? Click to login
Dihydroxyacetone as a definitive treatment for aluminium phosphide poisoning in rats Cover

Dihydroxyacetone as a definitive treatment for aluminium phosphide poisoning in rats

Open Access
|Jul 2018

References

  1. 1. Hashemi-Domeneh B, Zamani N, Hassanian-Moghaddam H, Rahimi M, Shadnia S, Erfantalab P, Ostadi A. A review of aluminium phosphide poisoning and a flowchart to treat it. Arh Hig Rada Toksikol 2016;67:183-93. doi: 10.1515/aiht-2016-67-278410.1515/aiht-2016-67-278427749266
  2. 2. Mohan B, Gupta V, Ralhan S, Gupta D, Puri S, Wander GS, Singh B. Role of extracorporeal membrane oxygenation in aluminum phosphide poisoning-Induced reversible myocardial dysfunction: A novel therapeutic modality. J Emerg Med 2015;49:651-6. doi: 10.1016/j.jemermed.2015.06.07110.1016/j.jemermed.2015.06.07126299790
  3. 3. Karami-Mohajeri S, Jafari A, Abdollahi M. Comprehensive review of the mechanistic approach and related therapies to cardiovascular effects of aluminum phosphide. Int J Pharmacol 2013;9:493-500. doi: 10.3923/ijp.2013.493.50010.3923/ijp.2013.493.500
  4. 4. Mehrpour O, Jafarzadeh M, Abdollahi M. A systematic review of aluminium phosphide poisoning. Arh Hig Rada Toksikol 2012;63:61-73. doi: 10.2478/10004-1254-63-2012-218210.2478/10004-1254-63-2012-218222450207
  5. 5. Yan H, Xiang P, Zhang S, Shen B, Shen M. Diagnosis of aluminum phosphide poisoning using a new analytical approach: forensic application to a lethal intoxication. Int J Legal Med 2017;131:1001-7. doi: 10.1007/s00414-017-1562-110.1007/s00414-017-1562-128243772
  6. 6. Schoonbroodt D, Guffens P, Jousten P, Ingels J, Grodos J. Acute phosphine poisoning? A case report and review. Acta Clin Belg 1992;47:280-4. doi: 10.1080/17843286.1992.1171824310.1080/17843286.1992.117182431329417
  7. 7. Bumbrah GS, Krishan K, Kanchan T, Sharma M, Sodhi GS. Phosphide poisoning: a review of literature. Forensic Sci Int 2012;214:1-6. doi: 10.1016/j.forsciint.2011.06.01810.1016/j.forsciint.2011.06.01821763089
  8. 8. Bashardoust B, Farzaneh E, Habibzadeh A, Seyyed Sadeghi MS. Successful treatment of severe metabolic acidosis due to acute aluminum phosphide poisoning with peritoneal dialysis: a report of 2 cases. Iran J Kidney Dis 2017;11:165-7. PMID: 28270650
  9. 9. Saleki S, Ardalan FA, Javidan-Nejad A. Liver histopathology of fatal phosphine poisoning. Forensic Sci Int 2007;166:190-3. doi: 10.1016/j.forsciint.2006.05.03310.1016/j.forsciint.2006.05.03316806774
  10. 10. Mendonca M, Tamas C, Kiraly L, Talo H, Rajah J. Successful use of ECLS in cardiopulmonary failure due to aluminum phosphide poising. Egypt J Crit Care Med 2016;4:33-5. doi: 10.1016/j.ejccm.2016.02.00410.1016/j.ejccm.2016.02.004
  11. 11. Mehrpour O, Amouzeshi A, Dadpour B, Oghabian Z, Zamani N, Amini S, Hoffman RS. Successful treatment of cardiogenic shock with an intraaortic balloon pump following aluminium phosphide poisoning. Arh Hig Rada Toksikol 2014;65:121-7. doi: 10.2478/10004-1254-65-2014-239310.2478/10004-1254-65-2014-239324445229
  12. 12. Hassanian-Moghaddam H, Zamani N, Rahimi M, Hajesmaeili M, Taherkhani M, Sadeghi R. Successful treatment of aluminium phosphide poisoning by extracorporeal membrane oxygenation. Basic Clin Pharmacol Toxicol 2016;118:243-6. doi: 10.1111/bcpt.1248110.1111/bcpt.12481
  13. 13. Marashi SM, Nasri Nasrabadi Z, Jafarzadeh M, Mohammadi S. Hydroxyethyl starch could save a patient with acute aluminum phosphide poisoning. Acta Med Iran 2016;54:475-8. PMID: 27424021
  14. 14. Jafari A, Baghaei A, Solgi R, Baeeri M, Chamanara M, Hassani S, Gholami M, Ostad SN, Sharifzadeh M, Abdollahi M. An electrocardiographic, molecular and biochemical approach to explore the cardioprotective effect of vasopressin and milrinone against phosphide toxicity in rats. Food Chem Toxicol 2015;80:182-92. doi: 10.1016/j.fct.2015.02.02210.1016/j.fct.2015.02.022
  15. 15. Azad A, Lall SB, Mittra S. Effect of N-acetylcysteine and L-NAME on aluminium phosphide induced cardiovascular toxicity in rats. Acta Pharmacol Sin 2001;22:298-304. PMID: 11742581
  16. 16. Erni B, Siebold C, Christen S, Srinivas A, Oberholzer A, Baumann U. Small substrate, big surprise: fold, function and phylogeny of dihydroxyacetone kinases. Cell Mol Life Sci 2006;63:890-900. doi: 10.1007/s00018-005-5518-010.1007/s00018-005-5518-0
  17. 17. Hirabayashi J. On the origin of elementary hexoses. Q Rev Biol 1996;71:365-80. PMID: 892769010.1086/419443
  18. 18. Jeffery J, Jörnvall H. Enzyme relationships in a sorbitol pathway that bypasses glycolysis and pentose phosphates in glucose-metabolism. Proc Natl Acad Sci USA 1983;80:901-5. doi: 10.1073/pnas.80.4.90110.1073/pnas.80.4.901
  19. 19. Macauley S, McNeil B, Harvey LM. The genus Gluconobacter and its applications in biotechnology. Crit Rev Biotechnol 2001;21:1-25. doi: 10.1080/2001389108166510.1080/20013891081665
  20. 20. Faurschou A, Janjua NR, Wulf HC. Sun protection effect of dihydroxyacetone. Arch Dermatol 2004;140:886-7. doi: 10.1001/archderm.140.7.88610.1001/archderm.140.7.886
  21. 21. Laborit H, inventor; Centre D’etudes Exper et Cliniques de Physiobiologi Pharm et Eut, assignee. Treatment of hemorrhagic shock. United States patent US4049795A. 1977 Sept 20.
  22. 22. Niknahad H, O’Brien PJ. Antidotal effect of dihydroxyacetone against cyanide toxicity in vivo. Toxicol Appl Pharmacol 1996;138:186-91. doi: 10.1006/taap.1996.011210.1006/taap.1996.0112
  23. 23. Niknahad H, Ghelichkhani E. Antagonism of cyanide poisoning by dihydroxyacetone. Toxicol Lett 2002;132:95-100. doi: 10.1016/S0378-4274(02)00016-410.1016/S0378-4274(02)00016-4
  24. 24. Rashedinia M, Jamshidzadeh A, Mehrabadi AR, Niknahad H. Prevention of phosphine-induced cytotoxicity by nutrients in HepG2 cells. Indian J Med Res 2016;144:560-5. doi: 10.4103/0971-5916.20089610.4103/0971-5916.200896534530228256464
  25. 25. Baeeri M, Shariatpanahi M, Baghaei A, Ghasemi-Niri SF, Mohammadi H, Mohammadirad A, Hassani S, Bayrami Z, Hosseini A, Rezayat SM, Abdollahi M. On the benefit of magnetic magnesium nanocarrier in cardiovascular toxicity of aluminum phosphide. Toxicol Ind Health 2013;29:126-35. doi: 10.1177/074823371142507410.1177/0748233711425074
  26. 26. Anand R, Kumari P, Kaushal A, Bal A, Wani WY, Sunkaria A, Dua R, Singh S, Bhalla A, Gill KD. Effect of acute aluminum phosphide exposure on rats: a biochemical and histological correlation. Toxicol Lett 2012;215:62-9. doi: 10.1016/j.toxlet.2012.09.02010.1016/j.toxlet.2012.09.020
  27. 27. Tehrani H, Halvaie Z, Shadnia S, Soltaninejad K, Abdollahi M. Protective effects of N-acetylcysteine on aluminum phosphide-induced oxidative stress in acute human poisoning. Clin Toxicol (Phila) 2013;51:23-8. doi: 10.3109/15563650.2012.74302910.3109/15563650.2012.743029
  28. 28. Joukar S, Zarisfi Z, Sepehri G, Bashiri A. Efficacy of Melissa officinalis in suppressing ventricular arrhythmias following ischemia-reperfusion of the heart: a comparison with amiodarone. Med Princ Pract 2014;23:340-5. doi: 10.1159/00036345210.1159/000363452
  29. 29. Frohlich M, Driessen A, Bohmer A, Nienaber U, Igressa A, Probst C, Bouillon B, Maegele M, Mutschler M, and the TraumaRegister DGU. Is the shock index based classification of hypovolemic shock applicable in multiple injured patients with severe traumatic brain injury?-an analysis of the TraumaRegister DGU®. Scand J Trauma Resusc Emerg Med 2016;24:148. doi: 10.1186/s13049-016-0340-210.1186/s13049-016-0340-2
  30. 30. Olaussen A, Blackburn T, Mitra B, Fitzgerald M. Review article: shock index for prediction of critical bleeding post-trauma: a systematic review. Emerg Med Australas 2014;26:223-8. doi: 10.1111/1742-6723.1223210.1111/1742-6723.12232
  31. 31. Allgöwer M, Burri C. Shock-index. Ger Med Mon 1968;13:14-9. PMID: 5656857
  32. 32. Rady MY. The role of central venous oximetry, lactic acid concentration and shock index in the evaluation of clinical shock: a review. Resuscitation 1992;24:55-60. doi: 10.1016/0300-9572(92)90173-A10.1016/0300-9572(92)90173-
  33. 33. Rady MY, Smithline HA, Blake H, Nowak R, Rivers E. A comparison of the shock index and conventional vital signs to identify acute, critical illness in the emergency department. Ann Emerg Med 1994;24:685-90. doi: 10.1016/S0196-0644(94)70279-910.1016/S0196-0644(94)70279-9
  34. 34. Merone M, Soda P, Sansone M, Sansone C. ECG databases for biometric systems: A systematic review. Expert Syst Appl 2017;67:189-202. doi: 10.1016/j.eswa.2016.09.03010.1016/j.eswa.2016.09.030
  35. 35. Fox K, Borer JS, Camm AJ, Danchin N, Ferrari R, Lopez Sendon JL, Steg PG, Tardif JC, Tavazzi L, Tendera M, Heart Rate Working Group. Resting heart rate in cardiovascular disease. J Am Coll Cardiol 2007;50:823-30. doi: 10.1016/j.jacc.2007.04.07910.1016/j.jacc.2007.04.07917719466
  36. 36. Soltaninejad K, Beyranvand MR, Momenzadeh SA, Shadnia S. Electrocardiographic findings and cardiac manifestations in acute aluminum phosphide poisoning. J Forensic Leg Med 2012;19:291-3. doi: 10.1016/j.jflm.2012.02.00510.1016/j.jflm.2012.02.00522687771
  37. 37. Baghaei A, Hajimohammadi N, Baeeri M, Mohammadirad A, Hassani S, Abdollahi M. On the protection of ALP cardiovascular toxicity by a Novel mixed herbal medicine; Role of oxidative stress and cellular ATP. Asian J Anim Vet Adv 2014;9:302-11. doi: 10.3923/ajava.2014.302.31110.3923/ajava.2014.302.311
  38. 38. Chugh SN, Dushyant, Ram S, Arora B, Malhotra KC. Incidence & outcome of aluminium phosphide poisoning in a hospital study. Indian J Med Res 1991;94:232-235. PMID: 1937606
  39. 39. Vandael E, Vandenberk B, Vandenberghe J, Willems R, Foulon V. Risk factors for QTc-prolongation: systematic review of the evidence. Int J Clin Pharm 2017;39:16-25. doi: 10.1007/s11096-016-0414-210.1007/s11096-016-0414-228012118
  40. 40. Atkuri KR, Mantovani JJ, Herzenberg LA, Herzenberg LA. N-Acetylcysteine - a safe antidote for cysteine/glutathione deficiency. Curr Opin Pharmacol 2007;7:355-9. doi: 10.1016/j.coph.2007.04.00510.1016/j.coph.2007.04.005454006117602868
  41. 41. Kemp SF, Lockey RF. Anaphylaxis: a review of causes and mechanisms. J Allergy Clin Immunol 2002;110:341-8. doi: 10.1067/mai.2002.12681110.1067/mai.2002.12681112209078
  42. 42. Valmas N, Zuryn S, Ebert PR. Mitochondrial uncouplers act synergistically with the fumigant phosphine to disrupt mitochondrial membrane potential and cause cell death. Toxicology 2008;252:33-9. doi: 10.1016/j.tox.2008.07.06010.1016/j.tox.2008.07.06018755236
  43. 43. Asghari MH, Abdollahi M, de Oliveira MR, Nabavi SM. A review of the protective role of melatonin during phosphine-induced cardiotoxicity: focus on mitochondrial dysfunction, oxidative stress and apoptosis. J Pharm Pharmacol 2017;69:236-43. doi: 10.1111/jphp.1268210.1111/jphp.1268228000313
  44. 44. Trakulsrichai S, Kosanyawat N, Atiksawedparit P, Sriapha C, Tongpoo A, Udomsubpayakul U, Rittilert P, Wananukul W. Clinical characteristics of zinc phosphide poisoning in Thailand. Ther Clin Risk Manag 2017;13:335-40. doi: 10.2147/TCRM.S12961010.2147/TCRM.S129610536039728352183
DOI: https://doi.org/10.2478/aiht-2018-69-3106 | Journal eISSN: 1848-6312 | Journal ISSN: 0004-1254
Language: English, Croatian, Slovenian
Page range: 169 - 177
Submitted on: Feb 1, 2018
Accepted on: May 1, 2018
Published on: Jul 7, 2018
Published by: Institute for Medical Research and Occupational Health
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2018 Jafar Ahmadi, Siyavash Joukar, Hussein Anani, Somayyeh Karami-Mohajeri, published by Institute for Medical Research and Occupational Health
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.